Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.
about
Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients.Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis.Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.Targeted therapy of cancer: new roles for pathologists in colorectal cancer.Accomplishments in 2007 in biologic markers for gastrointestinal cancersPrognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients.
P2860
Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Have we made progress in pharm ...... cular markers in colon cancer.
@ast
Have we made progress in pharm ...... cular markers in colon cancer.
@en
type
label
Have we made progress in pharm ...... cular markers in colon cancer.
@ast
Have we made progress in pharm ...... cular markers in colon cancer.
@en
prefLabel
Have we made progress in pharm ...... cular markers in colon cancer.
@ast
Have we made progress in pharm ...... cular markers in colon cancer.
@en
P2860
P356
P1433
P1476
Have we made progress in pharm ...... cular markers in colon cancer.
@en
P2093
Patrick G Johnston
Wendy L Allen
P2860
P304
P356
10.2217/14622416.6.6.603
P577
2005-09-01T00:00:00Z